Tag: therapeutics
March 30, 2019
New to the Investing News Network
New to the Investing News Network – November 2020 Tarku Resources Ltd. (TSXV:TKU) is a precious, base and strategic metals... March 13, 2019
NervGen Pharma Completes $10 Million Initial Public Offering; Shares to Commence Trading on TSX-V on March 15, 2019 – Symbol “NGEN”
NervGen Pharma Corp. ("NervGen" or the "Company"), a regenerative medicine company dedicated to creating innovative solutions for the treatment of... December 31, 2018
New to the Investing News Network
Here at the Investing News Network our mission is twofold; to provide the latest news and quality education by helping...
November 13, 2018
CRISPR Trials to Watch in 2018
CRISPR Cas-9 gene editing is finally in clinical studies. Here's an overview of CRISPR genetics testing trials currently in progress.
September 29, 2018
Cannabis Weekly Round-Up: Ontario Shares Retail Restrictions
The Investing News Network rounds up some of the biggest company and market news in the cannabis market for the...
September 28, 2018
Big News Roundup: The Flowr Corporation Goes Public on the TSXV; Cannvas Signs Letter of Intent with Advica Health; Pure Global Completes Initial Sales License Review and Launches Groundbreaking Medical Cannabis Research Study with Appletree Medical Group
In case you missed it, here is this week’s cannabis big news roundup.
September 28, 2018